The FDA’s 2025 update on tranexamic acid strengthens safety warnings for IV-only use and mandates new labeling. Learn how OctariusRx helps ASCs stay compliant and enhance medication safety.
Tag: FDA 2025 updates
The FDA’s 2025 update on tranexamic acid strengthens safety warnings for IV-only use and mandates new labeling. Learn how OctariusRx helps ASCs stay compliant and enhance medication safety.